Clinical Relevance of Torque Teno Virus (TTV) in HIV/HCV Coinfected and HCV Monoinfected Patients Treated with Direct-Acting Antiviral Therapy.

DAA therapy HIV/HCV coinfection Hepatitis C virus Torque Teno virus (TTV) cytokines

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
13 May 2021
Historique:
received: 22 04 2021
revised: 02 05 2021
accepted: 06 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 6 2021
Statut: epublish

Résumé

Torque Teno virus (TTV) is a ubiquitous virus that causes chronic infection in humans with unknown clinical consequences. Here, we investigated the influence of TTV infection on HCV direct-acting antiviral (DAA) efficacy in HIV/HCV coinfected and HCV monoinfected patients as controls. Of 92 study patients, 79.3% were TTV DNA positive; untreated patients exhibited a significantly higher proportion of TTV DNA-positivity vs. sustained virological response (SVR) patients (100.0% vs. 65.2%,

Identifiants

pubmed: 34068071
pii: jcm10102092
doi: 10.3390/jcm10102092
pmc: PMC8152458
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministero della Salute
ID : Ricerca corrente , linea 3

Références

Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
BMC Infect Dis. 2020 Dec 4;20(1):928
pubmed: 33276738
J Clin Microbiol. 2005 Sep;43(9):4807-10
pubmed: 16145145
Mem Inst Oswaldo Cruz. 2012 Aug;107(5):684-6
pubmed: 22850961
Hepatogastroenterology. 2001 Jan-Feb;48(37):256-60
pubmed: 11268979
Clin Infect Dis. 2016 Jul 15;63 Suppl 1:S3-S11
pubmed: 27363438
Eur J Clin Microbiol Infect Dis. 2013 Feb;32(2):289-97
pubmed: 22983402
Scand J Infect Dis. 2000;32(3):259-62
pubmed: 10879595
Curr Top Microbiol Immunol. 2009;331:21-33
pubmed: 19230555
J Med Virol. 2020 Jul 13;:
pubmed: 32658305
World J Gastroenterol. 2020 Apr 21;26(15):1691-1707
pubmed: 32351287
Microb Pathog. 2009 Jul;47(1):33-7
pubmed: 19409976
Curr Top Microbiol Immunol. 2009;331:1-20
pubmed: 19230554
AIDS. 2001 Mar 30;15(5):563-70
pubmed: 11316992
World J Gastroenterol. 2016 Sep 21;22(35):8050-9
pubmed: 27672299
J Clin Virol. 2015 Nov;72:106-13
pubmed: 26479202
PLoS One. 2015 Apr 20;10(3):e0122975
pubmed: 25894323
World J Gastroenterol. 2006 Apr 21;12(15):2432-6
pubmed: 16688839
J Gastroenterol Hepatol. 2000 Nov;15(11):1292-7
pubmed: 11129224
Transplantation. 2017 Jul;101(7):e219-e221
pubmed: 28263221
BMC Infect Dis. 2018 Jul 17;18(1):334
pubmed: 30016934
Clin Microbiol Infect. 2016 Jul;22(7):589-93
pubmed: 27093875
Cell. 2013 Nov 21;155(5):1178-87
pubmed: 24267896
Sci Rep. 2016 May 25;6:26739
pubmed: 27221159
J Med Virol. 2018 Jul;90(7):1264-1271
pubmed: 29611880
J Virol. 2007 Nov;81(21):11917-24
pubmed: 17686849
J Clin Pathol. 2005 Apr;58(4):402-5
pubmed: 15790705
Oncotarget. 2017 Nov 11;8(62):105800-105808
pubmed: 29285293
Pathol Biol (Paris). 2009 Feb;57(1):97-100
pubmed: 18842354
J Clin Virol. 2018 Aug;105:118-127
pubmed: 29957546
Virology. 2009 Nov 25;394(2):235-42
pubmed: 19765789
Front Microbiol. 2019 Sep 18;10:1898
pubmed: 31620095
Int Urol Nephrol. 2010 Dec;42(4):1077-83
pubmed: 19777363
HIV Clin Trials. 2002 Jul-Aug;3(4):287-95
pubmed: 12187502
J Med Virol. 2015 Jul;87(7):1184-91
pubmed: 25676255
Virus Res. 2020 Aug;285:198013
pubmed: 32404273
J Infect Dis. 2019 May 24;219(12):1934-1939
pubmed: 30668796
Gastroenterol Res Pract. 2012;2012:671927
pubmed: 23213328
Virology. 1999 Jul 5;259(2):428-36
pubmed: 10388666
Indian J Med Res. 2010 Apr;131:545-54
pubmed: 20424306
Curr Top Microbiol Immunol. 2009;331:109-16
pubmed: 19230560
J Med Virol. 2007 Jan;79(1):1-7
pubmed: 17133553
J Gen Virol. 2000 Sep;81(Pt 9):2273-2279
pubmed: 10950985
Hepatology. 1999 Jul;30(1):283-8
pubmed: 10385668
Biochem Biophys Res Commun. 1997 Dec 8;241(1):92-7
pubmed: 9405239
PLoS One. 2016 Feb 22;11(2):e0149901
pubmed: 26901643
J Virol. 2010 Jul;84(13):6891-3
pubmed: 20410268
Arch Virol. 2020 Mar;165(3):571-582
pubmed: 32030535
Int J Immunopathol Pharmacol. 2003 May-Aug;16(2):109-18
pubmed: 12797901
Arch Virol. 2001 Jul;146(7):1249-66
pubmed: 11556704
Arch Virol. 2009;154(8):1285-91
pubmed: 19585076
Infect Genet Evol. 2016 Oct;44:501-506
pubmed: 27510954
Nucleic Acids Res. 1997 Dec 15;25(24):4876-82
pubmed: 9396791
Mediators Inflamm. 2019 Nov 4;2019:4738237
pubmed: 31780860
J Infect Dis. 2000 May;181(5):1796-9
pubmed: 10823787

Auteurs

Daniele Lapa (D)

Laboratory of Virology, "Lazzaro Spallanzani" National Institute for Infectious Diseases, IRCCS, 00149 Rome, Italy.

Paola Del Porto (P)

Department of Biology and Biotechnology "C. Darwin", Sapienza University, 00185 Rome, Italy.

Claudia Minosse (C)

Laboratory of Virology, "Lazzaro Spallanzani" National Institute for Infectious Diseases, IRCCS, 00149 Rome, Italy.

Gianpiero D'Offizi (G)

Hepatology and Infectious Diseases Unit, "Lazzaro Spallanzani" National Institute for Infectious Diseases IRCCS, 00149 Rome, Italy.

Andrea Antinori (A)

Clinical Department, "Lazzaro Spallanzani " National Institute for Infectious Diseases, IRCCS, 00149 Rome, Italy.

Maria Rosaria Capobianchi (MR)

Laboratory of Virology, "Lazzaro Spallanzani" National Institute for Infectious Diseases, IRCCS, 00149 Rome, Italy.

Ubaldo Visco-Comandini (U)

Hepatology and Infectious Diseases Unit, "Lazzaro Spallanzani" National Institute for Infectious Diseases IRCCS, 00149 Rome, Italy.

Fiona McPhee (F)

Bristol-Myers Squibb, Cambridge, MA 02142, USA.

Anna Rosa Garbuglia (AR)

Laboratory of Virology, "Lazzaro Spallanzani" National Institute for Infectious Diseases, IRCCS, 00149 Rome, Italy.

Mauro Zaccarelli (M)

Clinical Department, "Lazzaro Spallanzani " National Institute for Infectious Diseases, IRCCS, 00149 Rome, Italy.

Classifications MeSH